Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Pulmonary Hypertension, February 2018

Free Subscription


Abstracts

Retrieve all available abstracts of the following 79 articles:
HTML format


 

Single Articles

  1. DURMUS N, Grunig G
    Polymorphonuclear Leukocytes in Pulmonary Hypertension and Fibrosis: Not Always What They Appear to Be.
    Am J Respir Cell Mol Biol. 2018;58:135-137.
    Abstract    



  2. PATEL HR, Bhutani S, Shamoon F, Virk H, et al
    Deciphering a case of pulmonary hypertension in a young female: Partial anomalous pulmonary venous drainage the culprit.
    Ann Thorac Med. 2018;13:55-58.
    Abstract    

    Abstract available

  3. STENMARK KR, Frid MG, Graham BB, Tuder RM, et al
    Dynamic and Diverse Changes in the Functional Properties of Vascular Smooth Muscle Cells in Pulmonary Hypertension.
    Cardiovasc Res. 2018 Jan 27. pii: 4827634. doi: 10.1093.
    Abstract    

    Abstract available

  4. VEZZOSI T, Domenech O, Iacona M, Marchesotti F, et al
    Echocardiographic Evaluation of the Right Atrial Area Index in Dogs with Pulmonary Hypertension.
    J Vet Intern Med. 2018;32:42-47.
    Abstract    

    Abstract available

  5. AKIN A, Alehan D, Aykan HH, Ozkutlu S, et al
    Evaluation of Tissue Doppler Echocardiographic Imaging findings in children with pulmonary hypertension.
    Turk J Pediatr. 2017;59:244-253.
    Abstract    

    Abstract available

  6. NIE X, Tan J, Dai Y, Liu Y, et al
    CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
    J Mol Cell Cardiol. 2018 Jan 25. pii: S0022-2828(18)30025.
    Abstract    

    Abstract available

  7. MIYAZAKI S, Ikeda T, Ito G, Inoue M, et al
    Pulmonary tumor thrombotic microangiopathy successfully treated with corticosteroids: a case report.
    J Med Case Rep. 2017;11:356.
    Abstract    

    Abstract available

  8. LONG BD, Stojanovska J, Brown RKJ, Attili AK, et al
    Increased Epicardial Fat Volume Is Independently Associated with the Presence and Severity of Systemic Sclerosis.
    Acad Radiol. 2017;24:1473-1481.
    Abstract    

    Abstract available

  9. DEL POZO R, Hernandez Gonzalez I, Escribano-Subias P
    The prostacyclin pathway in pulmonary arterial hypertension: a clinical review.
    Expert Rev Respir Med. 2017;11:491-503.
    Abstract    

    Abstract available

  10. ISSAC M, Dingemanse J, Sidharta PN
    Pharmacokinetics of Macitentan in Patients With Pulmonary Arterial Hypertension and Comparison With Healthy Subjects.
    J Clin Pharmacol. 2017;57:997-1004.
    Abstract    

    Abstract available

  11. LUBBERTS B, Paulino Pereira NR, Kabrhel C, Kuter DJ, et al
    What is the effect of venous thromboembolism and related complications on patient reported health-related quality of life? A meta-analysis.
    Thromb Haemost. 2016;116.
    Abstract    

    Abstract available

  12. KRAEMER US, Leeuwen L, Krasemann TB, Wijnen RMH, et al
    Characteristics of Infants With Congenital Diaphragmatic Hernia Who Need Follow-Up of Pulmonary Hypertension.
    Pediatr Crit Care Med. 2018 Feb 6. doi: 10.1097/PCC.0000000000001464.
    Abstract    

    Abstract available

  13. RAMU B, Houston BA, Tedford RJ
    Pulmonary Vascular Disease: Hemodynamic Assessment and Treatment Selection-Focus on Group II Pulmonary Hypertension.
    Curr Heart Fail Rep. 2018 Feb 7. pii: 10.1007/s11897-018-0377.
    Abstract    

    Abstract available

  14. CHEN TX, Pudasaini B, Guo J, Gong SG, et al
    Sex-specific cardiopulmonary exercise testing indices to estimate the severity of inoperable chronic thromboembolic pulmonary hypertension.
    Int J Chron Obstruct Pulmon Dis. 2018;13:385-397.
    Abstract    

    Abstract available

  15. PRASAD JD
    Screening for pulmonary hypertension in interstitial lung disease: Many reasons to ECHO!
    Respirology. 2018 Feb 7. doi: 10.1111/resp.13263.
    Abstract    



  16. SARYBAEV AS, Sydykov AS, Sartmyrzaeva MA, Mamazhakypov AT, et al
    [Diagnosis and treatment of pulmonary hypertension: from the point of view of 2017].
    Ter Arkh. 2017;89:127-132.
    Abstract    

    Abstract available

  17. CHEN X, Zhai Z, Huang K, Xie W, et al
    Bosentan Therapy for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: A Systemic Review and Meta-Analysis.
    Clin Respir J. 2018 Feb 2. doi: 10.1111/crj.12774.
    Abstract    

    Abstract available

  18. HIGO K, Kubota K, Miyanaga S, Miyata M, et al
    Impairment of Iodine-123-Metaiodobenzylguanidine ((123)I-MIBG) Uptake in Patients with Pulmonary Artery Hypertension.
    Int Heart J. 2018;59:112-119.
    Abstract    

    Abstract available

  19. SACUTO T, Sacuto Y
    Cardiopulmonary bypass does not induce lung dysfunction after pulmonary thrombarterectomy: role of pulmonary compliance.
    Interact Cardiovasc Thorac Surg. 2017;25:930-936.
    Abstract    

    Abstract available

  20. MADDEN BP, Shaw EJ
    Skeletal muscle exercise training in pulmonary arterial hypertension.
    Int J Cardiol. 2017;246:59-60.
    Abstract    



  21. TALWAR S, Siddharth B, Gupta SK, Choudhary SK, et al
    Aortopulmonary window: results of repair beyond infancy.
    Interact Cardiovasc Thorac Surg. 2017;25:740-744.
    Abstract    

    Abstract available

  22. ENDERLE Y, Witt L, Wilkens H, Grunig E, et al
    Simultaneous quantification of endothelin receptor antagonists and phosphodiesterase 5 inhibitors currently used in pulmonary arterial hypertension.
    J Pharm Biomed Anal. 2017;143:291-298.
    Abstract    

    Abstract available

  23. SEKAR D, Shilpa BR, Das AJ
    Relevance of microRNA 21 in Different Types of Hypertension.
    Curr Hypertens Rep. 2017;19:57.
    Abstract    

    Abstract available

  24. KIM H, Bae Lee J, Park JH, Yoo BS, et al
    A comparison of echocardiographic variables of right ventricular function with exercise capacity after bosentan treatment in patients with pulmonary arterial hypertension: Results from a multicenter, prospective, cohort study.
    J Clin Ultrasound. 2017;45:28-34.
    Abstract    

    Abstract available

  25. MAO M, Zhang M, Ge A, Ge X, et al
    Granzyme B deficiency promotes osteoblastic differentiation and calcification of vascular smooth muscle cells in hypoxic pulmonary hypertension.
    Cell Death Dis. 2018;9:221.
    Abstract    

    Abstract available

  26. MATHAI SC, Ryan JJ
    The Growing Burden of Pulmonary Hypertension in the Modern Era: A Zebra No More?
    Circ Cardiovasc Qual Outcomes. 2018;11:e004536.
    Abstract    



  27. WIJERATNE DT, Lajkosz K, Brogly SB, Lougheed MD, et al
    Increasing Incidence and Prevalence of World Health Organization Groups 1 to 4 Pulmonary Hypertension: A Population-Based Cohort Study in Ontario, Canada.
    Circ Cardiovasc Qual Outcomes. 2018;11:e003973.
    Abstract    

    Abstract available

  28. LI D, Wang B, Wang H, Liu Q, et al
    Prognostic significance of pulmonary hypertension in patients with cystic fibrosis: A systematic review and meta-analysis.
    Medicine (Baltimore). 2018;97:e9708.
    Abstract    

    Abstract available

  29. JAIN S, Bachani NS, Pinto RJ, Dalvi BV, et al
    Dual pathology causing severe pulmonary hypertension following surgical repair of total anomalous pulmonary venous connection: Successful outcome following serial transcatheter interventions.
    Ann Pediatr Cardiol. 2018;11:79-82.
    Abstract    

    Abstract available

  30. GILLIS HC, Fischer G, Gupta S
    Treatment of pulmonary hypertension with inhaled agents in the pediatric intensive care unit.
    Am J Health Syst Pharm. 2018;75:171-172.
    Abstract    



  31. HOETTE S, Creuze N, Gunther S, Montani D, et al
    RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study.
    Lung. 2018 Feb 12. pii: 10.1007/s00408-018-0089.
    Abstract    

    Abstract available

  32. MEYER GMB, Spilimbergo FB, Atmayer S, Pacini GS, et al
    Multiparametric Magnetic Resonance Imaging in the Assessment of Pulmonary Hypertension: Initial Experience of a One-Stop Study.
    Lung. 2018 Feb 12. pii: 10.1007/s00408-018-0097.
    Abstract    

    Abstract available

  33. ALUJA JARAMILLO F, Gutierrez FR, Diaz Telli FG, Yevenes Aravena S, et al
    Approach to Pulmonary Hypertension: From CT to Clinical Diagnosis.
    Radiographics. 2018 Feb 12:170046. doi: 10.1148/rg.2018170046.
    Abstract    

    Abstract available

  34. TANG M, Batty JA, Lin C, Fan X, et al
    Pulmonary Hypertension, Mortality, and Cardiovascular Disease in CKD and ESRD Patients: A Systematic Review and Meta-analysis.
    Am J Kidney Dis. 2018 Feb 8. pii: S0272-6386(17)31138.
    Abstract    

    Abstract available

  35. FENG Z, Hu Y, An NN, Feng WJ, et al
    [Effect of acidic oligosaccharides on P-selectin of pulmonary hypertensive rats induced by monocrotaline].
    Zhonghua Jie He He Hu Xi Za Zhi. 2018;41:90-94.
    Abstract    

    Abstract available

  36. LIU S
    [Therapy of hemoptysis caused by pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2018;41:81-82.
    Abstract    



  37. DUPUIS M, Noel-Savina E, Prevot G, Tetu L, et al
    Determination of Cardiac Output in Pulmonary Hypertension Using Impedance Cardiography.
    Respiration. 2018 Feb 9. pii: 000486423. doi: 10.1159/000486423.
    Abstract    

    Abstract available

  38. YOSHIHISA A, Kimishima Y, Kiko T, Sato Y, et al
    Liver fibrosis marker, 7S domain of collagen type IV, in patients with pre-capillary pulmonary hypertension.
    Int J Cardiol. 2018 Feb 7. pii: S0167-5273(17)36007.
    Abstract    

    Abstract available

  39. ALKHODAIR A, Tsang MYC, Cairns JA, Swiston JR, et al
    Comparison of thermodilution and indirect Fick cardiac outputs in pulmonary hypertension.
    Int J Cardiol. 2018 Feb 2. pii: S0167-5273(17)34444.
    Abstract    

    Abstract available

  40. MENG X, Li Y, Li H, Wang Y, et al
    Right atrial function in patients with pulmonary hypertension: A study with two-dimensional speckle-tracking echocardiography.
    Int J Cardiol. 2018;255:200-205.
    Abstract    

    Abstract available

  41. RUGGERI P, Lo Bello F, Nucera F, Gaeta M, et al
    Hereditary hyperhomocysteinemia associated with nephrotic syndrome complicated by artery thrombosis and chronic thromboembolic pulmonary hypertension: A case report.
    Monaldi Arch Chest Dis. 2017;87:880.
    Abstract    

    Abstract available

  42. PARK MA, Shin SY, Kim YJ, Park MJ, et al
    Vascular Ehlers-Danlos syndrome with cryptorchidism, recurrent pneumothorax, and pulmonary capillary hemangiomatosis-like foci: A case report.
    Medicine (Baltimore). 2017;96:e8853.
    Abstract    

    Abstract available

  43. PYNE NJ, Pyne S
    Sphingosine Kinase 1: A Potential Therapeutic Target in Pulmonary Arterial Hypertension?
    Trends Mol Med. 2017;23:786-798.
    Abstract    

    Abstract available

  44. BRITTAIN EL, Nwabuo C, Xu M, Gupta DK, et al
    Echocardiographic Pulmonary Artery Systolic Pressure in the Coronary Artery Risk Development in Young Adults (CARDIA) Study: Associations With Race and Metabolic Dysregulation.
    J Am Heart Assoc. 2017;6.
    Abstract    

    Abstract available

  45. ORTIZ-BAUTISTA C, Hernandez-Gonzalez I, Escribano-Subias P
    Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.
    Med Clin (Barc). 2017;148:265-270.
    Abstract    

    Abstract available

  46. SHI YP, Li YD, Lv XZ, Yang YH, et al
    Systemic-pulmonary arteriovenous fistulae with pulmonary hypertension: A case report.
    Medicine (Baltimore). 2018;97:e9959.
    Abstract    

    Abstract available

  47. VONK-NOORDEGRAAF A, Westerhof BE
    The success of pulmonary hypertension treatment: improved cardiac function by reducing the arterial load.
    Pulm Circ. 2018;8:2045894018761632.
    Abstract    



  48. AGGARWAL M, Grady RM
    Treatment of Pediatric Pulmonary Hypertension.
    Curr Treat Options Cardiovasc Med. 2018;20:8.
    Abstract    

    Abstract available

  49. DOLGUN ZN, Inan C, Sayin NC
    Maternal and fetal outcomes in pregnancies with pulmonary hypertension: Experience of a tertiary center.
    Taiwan J Obstet Gynecol. 2018;57:13-17.
    Abstract    

    Abstract available

  50. KATZ N, Bar-Or Y, Raucher-Sterrnfeld A, Tamir A, et al
    Persistent Pulmonary Hypertension and Histologic Chorioamnionitis in Preterm Infants: Controlled Study.
    Pediatr Cardiol. 2018 Feb 16. pii: 10.1007/s00246-018-1809.
    Abstract    

    Abstract available

  51. PATHAK V, Suwal K
    Postoperative Outcome in Patients with Pulmonary Hypertension Undergoing Elective Non-Cardiac Surgery.
    JNMA J Nepal Med Assoc. 2017;56:438-441.
    Abstract    

    Abstract available

  52. KRAMM T, Wilkens H, Fuge J, Schafers HJ, et al
    Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany.
    Clin Res Cardiol. 2018 Feb 15. pii: 10.1007/s00392-018-1215.
    Abstract    

    Abstract available

  53. ROCHON ER, Corti P, Gladwin MT
    Hemoglobin alpha in Pulmonary Endothelium: Ironing Out Nitric Oxide Signaling.
    Am J Respir Cell Mol Biol. 2017;57:639-641.
    Abstract    



  54. LIU G, Thannickal VJ
    The Lung Likes the Little Fella miR-29.
    Am J Respir Cell Mol Biol. 2017;57:637-638.
    Abstract    



  55. HOUSSAINI A, Adnot S
    mTOR: A Key to Both Pulmonary Vessel Remodeling and Right Ventricular Function in Pulmonary Arterial Hypertension?
    Am J Respir Cell Mol Biol. 2017;57:509-511.
    Abstract    



  56. VANDERPOOL RR, Tang H, Rischard F, Yuan JX, et al
    Is p38 MAPK a Dark Force in Right Ventricular Hypertrophy and Failure in Pulmonary Arterial Hypertension?
    Am J Respir Cell Mol Biol. 2017;57:506-508.
    Abstract    



  57. THISTLETHWAITE PA
    Linking Vascular Remodeling and Inflammation in Pulmonary Arterial Hypertension: Is There a Common Root Cause?
    Am J Respir Cell Mol Biol. 2017;57:15-17.
    Abstract    



  58. YAN C, Wang X, Su H, Ying K, et al
    Recent Progress in Research on the Pathogenesis of Pulmonary Thromboembolism: An Old Story with New Perspectives.
    Biomed Res Int. 2017;2017:6516791.
    Abstract    

    Abstract available

  59. SALLMON H, Hatch A, Murthy SK, Plouffe BD, et al
    Circulating Endothelial Cell Quantification by Microfluidics Chip in Pulmonary Arterial Hypertension.
    Am J Respir Cell Mol Biol. 2017;56:680-682.
    Abstract    



  60. PEREZ VAJ
    Long-Term Right Ventricular Adaptation to Postnatal Hyperoxia: Too Much of a Good Thing?
    Am J Respir Cell Mol Biol. 2017;56:559-560.
    Abstract    



  61. ALSINA CASANOVA M, Monteagudo-Sanchez A, Rodiguez Guerineau L, Court F, et al
    Maternal mutations of FOXF1 cause alveolar capillary dysplasia despite not being imprinted.
    Hum Mutat. 2017;38:615-620.
    Abstract    

    Abstract available

  62. RANCHOUX B, Bigorgne A, Hautefort A, Girerd B, et al
    Gut-Lung Connection in Pulmonary Arterial Hypertension.
    Am J Respir Cell Mol Biol. 2017;56:402-405.
    Abstract    



  63. BAERTLING F, Al-Murshedi F, Sanchez-Caballero L, Al-Senaidi K, et al
    Mutation in mitochondrial complex IV subunit COX5A causes pulmonary arterial hypertension, lactic acidemia, and failure to thrive.
    Hum Mutat. 2017;38:692-703.
    Abstract    

    Abstract available

  64. HENSLEY MK, Levine A, Gladwin MT, Lai YC, et al
    Emerging Therapeutics in Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2018 Feb 1. doi: 10.1152/ajplung.00259.2017.
    Abstract    

    Abstract available


  65. Chronic Thromboembolic Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018;197:P5-P6.
    Abstract    



  66. LEARY PJ, Hess E, Baron AE, Branch KR, et al
    H2-receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program.
    Am J Respir Crit Care Med. 2018 Feb 13. doi: 10.1164/rccm.201801-0048.
    Abstract    



  67. ELINOFF JM, Agarwal R, Barnett CF, Benza RL, et al
    Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg.
    Am J Respir Crit Care Med. 2018 Feb 9. doi: 10.1164/rccm.201710-2093.
    Abstract    

    Abstract available

  68. NAEIJE R, Saggar R, Badesch D, Rajagopalan S, et al
    Exercise-Induced Pulmonary Hypertension Translating Pathophysiological Concepts into Clinical Practice.
    Chest. 2018 Jan 27. pii: S0012-3692(18)30161-2. doi: 10.1016/j.chest.2018.
    Abstract    

    Abstract available

  69. HUSSAIN A, Bennett R, Haqzad Y, Qadri S, et al
    The differential effects of systemic vasoconstrictors on human pulmonary artery tension.
    Eur J Cardiothorac Surg. 2017;51:880-886.
    Abstract    

    Abstract available

  70. PAK O, Scheibe S, Esfandiary A, Gierhardt M, et al
    Impact of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension.
    Eur Respir J. 2018 Feb 1. pii: 13993003.01024-2017.
    Abstract    

    Abstract available

  71. CARAVITA S, Dewachter C, Soranna D, Carolino D'Araujo S, et al
    Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis.
    Eur Respir J. 2018 Feb 8. pii: 13993003.02427-2017.
    Abstract    



  72. HSU S, Tedford RJ
    Will we be singing a different tune on combined post- and pre-capillary pulmonary hypertension?
    Eur Respir J. 2018;51.
    Abstract    



  73. VACHIERY JL, Delcroix M, Al-Hiti H, Efficace M, et al
    Macitentan in pulmonary hypertension due to left ventricular dysfunction.
    Eur Respir J. 2018;51.
    Abstract    

    Abstract available

  74. CLAESSEN G, La Gerche A
    Stressing the right ventricular-pulmonary vascular unit: beyond pulmonary vascular resistance.
    Heart. 2017;103:404-406.
    Abstract    



  75. JIMENEZ D, Quezada CA, Escribano P
    Surrogate Endpoints for Pulmonary Hypertension Management and Trial Design: Moving in the Right Direction.
    J Am Coll Cardiol. 2018;71:764-765.
    Abstract    



  76. HOSHINO K, Takita K, Demura M, Kubo T, et al
    Systolic Anterior Motion of the Mitral Valve During Pulmonary Endarterectomy in a Patient with Chronic Thromboembolic Pulmonary Hypertension: A Case Report.
    J Cardiothorac Vasc Anesth. 2017 Jun 16. pii: S1053-0770(17)30570.
    Abstract    



  77. ABID S, Kebe K, Houssaini A, Tomberli F, et al
    New NO Donor NCX 1443: Therapeutic Effects on Pulmonary Hypertension in the SAD Mouse Model of Sickle Cell Disease.
    J Cardiovasc Pharmacol. 2018 Feb 8. doi: 10.1097/FJC.0000000000000570.
    Abstract    

    Abstract available

  78. DEY S, Parveen A, Tarrant KJ, Licknack T, et al
    Whole genome resequencing identifies the CPQ gene as a determinant of ascites syndrome in broilers.
    PLoS One. 2018;13:e0189544.
    Abstract    

    Abstract available

  79. GREINER S, Jud A, Aurich M, Geisenberger C, et al
    Prognostic relevance of elevated pulmonary arterial pressure assessed non-invasively: Analysis in a large patient cohort with invasive measurements in near temporal proximity.
    PLoS One. 2018;13:e0191206.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;